Analisis Kinerja Keuangan pada Sub Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia Menggunakan Metode Economic Value Added dan Market Value Added
DOI:
https://doi.org/10.30649/jab.v2i2.122Keywords:
Financial Performance, Economic Value Added, Market Value AddeAbstract
The pharmaceutical industry experienced growth from 2019 to 2021, driven by increased demand for medicines. However, in 2022, the growth of the pharmaceutical industry slowed down due to the impact of the Covid-19 pandemic in Indonesia. This research aims to describe the financial performance conditions of pharmaceutical sub-sector companies, measured using the Economic Value Added (EVA) and Market Value Added (MVA) methods. The research method used is a quantitative method with a descriptive approach. The type of data used is secondary data obtained from the website www.idx.co.id. The sample selection was carried out using purposive sampling technique, resulting in a total of 10 pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange (BEI) during the period from 2019 to 2022. The results of the financial performance analysis of companies using the EVA method indicate that pharmaceutical sub-sector companies have a good performance as they were able to generate a positive Economic Value Added (EVA > 0), signifying that the companies generated profits greater than the cost of capital, thus indicating good financial performance. Meanwhile, the financial performance analysis using the MVA method shows that pharmaceutical sub-sector companies were able to produce a positive Market Value Added (MVA > 0), indicating that the performance of the pharmaceutical sub-sector is in a good condition as the market value of the companies experienced an increase that exceeds the total capital invested by shareholders.
References
Badan Pusat Statistik. (2020). [Seri 2010] Laju Pertumbuhan PDB Seri 2010 (Persen). Retrieved from Badan Pusat Statistik: https://www.bps.go.id/indikator/indikator/view_data/0000/data/104/sdgs_17/1
Badan Pusat Statistik. (2020). Analisis Hasil Survei Dampak Covid-19 Terhadap Pelaku Usaha. Retrieved from Badan Pusat Statistik: https://www.bps.go.id/publication/2020/09/15/9efe2fbda7d674c09ffd0978/analisis-hasil-survei-dampak-covid-19-terhadap-pelaku-usaha.html
Badan Pusat Statistik. (2020). Ekonomi Indonesia 2019 Tumbuh 5,02 Persen. Retrieved from Badan Pusat Statistik: https://www.bps.go.id/pressrelease/2020/02/05/1755/ekonomi-indonesia-2019-tumbuh-5-02-persen.html
Badan Pusat Statistik. (2021). Ekonomi Indonesia 2020 Turun sebesar 2,07 Persen (c-to-c). Retrieved from Badan Pusat Statistik: https://www.bps.go.id/pressrelease/2021/02/05/1811/ekonomi-indonesia-2020-turun-sebesar-2-07-persen--c-to-c-.html
Badan Pusat Statistik. (2022). Ekonomi Indonesia Triwulan IV 2021 Tumbuh 5,02 Persen (y-on-y). Retrieved from Badan Pusat Statistik: https://www.bps.go.id/pressrelease/2022/02/07/1911/ekonomi-indonesia-triwulan-iv-2021-tumbuh-5-02-persen--y-on-y-.html
Badan Pusat Statistik. (2023). Ekonomi Indonesia Tahun 2022 Tumbuh 5,31 Persen. Retrieved from Badan Pusat Statistika: https://www.bps.go.id/pressrelease/2023/02/06/1997/ekonomi-indonesia-tahun-2022-tumbuh-5-31-persen.html
Brigham, E. F., & Houston, J. F. (2018). Dasar-Dasar Manajemen Keuangan. Jakarta: Salemba Empat.
Bursa Efek Indonesia. (2021). Laporan Keuangan dan Tahunan. Retrieved from idx: https://www.idx.co.id/id/perusahaan-tercatat/laporan-keuangan-dan-tahunan/
Dewi, M. (2017). Penilaian Kkinerja Keuangan Perusahaan dengan Menggunakan Metode EVA (Economic Value Added) (Studi Kasus pada PT. Krakatau Steel Tbk Periode 2012-2016). Jurnal Manajemen dan Keuangan, 648-659.
Eskasari, W. M. (2012). Analisis Kinerja Keuangan Perusahaan dengan Menggunakan Pendekatan Economic Value Added (EVA) dan Market Value Added (MVA) pada Perusahaan Farmasi yang Go Public di Bursa Efek Indonesia Tahun 2008-2011. Jurnal Ilmiah Mahasiswa FEB.
Indonesia, C. (2021). Saham Farmasi Hijau di Tengah Lonjakan Kasus Covid-19. Retrieved from CNN Indonesia: https://www.cnnindonesia.com/ekonomi/20210712181900-92-666686/saham-farmasi-hijau-di-tengah-lonjakan-kasus-covid-19
Jatnika, A. (2022). Airlangga: Industri Kesehatan Menjadi Fokus Pemerintah Saat Ini. Retrieved from Nasional Kontan: https://nasional.kontan.co.id/news/airlangga-industri-kesehatan-menjadi-fokus-pemerintah-saat-ini
Kementerian Perindustrian Republik Indonesia. (2021). Kinerja Industri. Retrieved from Kementerian Perindustrian Republik Indonesia: https://kemenperin.go.id/kinerja-industri
Lidwina, A. (2020). Persentase Perubahan Konsumsi Masyarakat. Retrieved from databoks: https://databoks.katadata.co.id/datapublish/2020/06/29/perubahan-pola-konsumsi-masyarakat-selama-pandemi-covid-19
Musleh, M. (2023). Tata Kelola Wisata Pulau Gili Iyang : Perspektif Community Based Tourism. Journal of Contemporary Public Administration, 3(1), 42–50. https://doi.org/10.22225/jcpa.3.1.6853.42-50
Musleh, M., Subianto, A., & Prasita, V. D. (2023). Stakeholder Interaction in the Development of Oxygen Ecotourism on Gili Iyang Island, Indonesia. Journal of Government Civil Society, 7(2), 297–323. https://doi.org/10.31000/jgcs.v7i2.8251
Musleh, M., Subianto, A., Tamrin, M. H., & Bustami, M. R. (2023). The Role of Institutional Design and Enabling Environmental : Collaborative Governance of a Pilgrimage Tourism , Indonesia. Journal of Local Government Issues (LOGOS), 6(1), 75–90. https://doi.org/10.22219/logos.v6i1.22218
Najmudin. (2011). Manajemen Keuangan dan Akuntansi Syar'iyyah. Yogyakarta: CV Andi Offset.
Setiawati, S. (2023). Sektor Kesehatan dan Farmasi Menghijau, Masa Depannya Cerah? Retrieved from CNBC Indonesia: https://www.cnbcindonesia.com/research/20230130102840-128-409202/sektor-kesehatan-dan-farmasi-menghijau-masa-depannya-cerah
Subramanyam, K. R., & Wild, J. J. (2010). Analisis Laporan Keuangan: financial tatement analysis. Jakarta: Salemba Medika.
Sugiyono. (2018). Metode Penelitian Kuantitatif, Kualitatif dan R&D. Bandung: Alfabeta.
Sutrisno. (2012). Manajemen Keuangan Teori, Konsep dan Aplikasi. Yogyakarta: EKONISIA.
Triatmojo, J. (2011). Model Terbaik Dalam Memprediksi Return On Equity (ROE) atau Economic Value Added (EVA). Media Riset Akuntansi, 141-157.
Winarto, Y. (2022). Selama Pandemi, Industri Farmasi Catatkan Penjualan Capai Rp 95 Triliun. Retrieved from Kontan: https://newssetup.kontan.co.id/news/selama-pandemi-industri-farmasi-catatkan-penjualan-capai-rp-95-triliun
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal Of Accounting and Business
This work is licensed under a Creative Commons Attribution 4.0 International License.
